Published date: 17 October 2019

Last edited date: 17 October 2019

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 14 June 2019

Contract summary

Industry

  • Vaccines - 33651600

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

tender_195395/801598

Published date

17 October 2019

Closing date

14 June 2019

Contract start date

1 January 2021

Contract end date

31 December 2022

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of a vaccine to protect against Haemophilus influenzae type B (Hib) and meningitis C (MenC), to be used in the national childhood immunisation programme.
The contracting authority estimates their requirement over the period of the contract to be up to 3 000 000 doses.
Deliveries will be required over a period of 2 years.
Previously advised the market that a contract will be awarded for the supply of haemophilus influenza type b, meningococcal C vaccine (Hib/Men c), which has been concluded.
VEAT reference : 2019/S 187-454780

More information

Attachments

Award information

Awarded date

8 October 2019

Contract start date

1 January 2021

Contract end date

31 December 2022

Total value of contract

£0

This contract was awarded to 1 supplier.

GlaxoSmithKline UK Ltd

Address

980 Great West Road, Brentford, TW8 9GS

Reference

Companies House number: 4310159

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

natalie.howell@dhsc.gov.uk